EM
NXTM

EnTrustPermal Management’s NxStage Medical Inc. NXTM Stock Holding History

EnTrustPermal Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$3.67M Buy
+132,900
New +$3.54M 1.53% 12

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

EnTrustPermal Management's NXTM Position: Q3 2017 in Review

EnTrustPermal Management opened a new position in NxStage Medical Inc. (NXTM) in Q3 2017: 132,900 shares worth $3.67M. The stake represents 1.53% of the portfolio and ranks #12 among its holdings.

168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • EnTrustPermal Management held 132,900 shares of NxStage Medical Inc. worth $3.67M as of Q3 2017.
  • NxStage Medical Inc. was a new EnTrustPermal Management position in Q3 2017.
  • NxStage Medical Inc. made up 1.53% of EnTrustPermal Management's portfolio in Q3 2017, its #12 holding.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on EnTrustPermal Management's 13F filing for Q3 2017, filed 14 Nov 2017.